| Amber N Haag, PHARMD | |
|
1400 W 12th Ave, Emporia, KS 66801-2516 | |
| (620) 342-1242 | |
| (620) 342-1243 |
| Full Name | Amber N Haag |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1400 W 12th Ave, Emporia, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619364205 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-13450 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amber N Haag, PHARMD 1400 W 12th Ave, Emporia, KS 66801-2516 Ph: (620) 342-1242 | Amber N Haag, PHARMD 1400 W 12th Ave, Emporia, KS 66801-2516 Ph: (620) 342-1242 |
News Archive
After a White House meeting with President Barack Obama Tuesday, Speaker of the House Nancy Pelosi, D-Calif., said there is "plenty to work with" to successfully overhaul the U.S. healthcare system, Reuters reports. She added that healthcare reform "will be done in a fiscally sound way."
Treating limited stage small cell lung cancer(LSCL) with a combination of accelerated high-dose radiotherapy and chemotherapy has shown encouraging results, opening the door to larger scale investigation, according to new research from The University of Texas M. D. Anderson Cancer Center.
Arrayit Corporation today announced the sale of a system to the Center of Excellence for Nucleic Acid-Based Technologies (CENAT) in Poznan, Poland. The Arrayit NanoPrint Microarrayer will be used by CENAT for scientific and medical collaborations throughout the prosperous democracy.
Over the last few decades, researchers have developed artificial enzymes for many applications. Recently, they deployed nanomaterial-based enzyme mimetics or nanozymes in diagnosis and therapeutics. Nanozymes find applications in various biomedical applications, including antiviral agents and cancer therapy.
Platform therapeutic company Symic Biomedical, Inc. announced today that it has received a $1.5M Phase II SBIR grant from the National Institutes of Health to further develop its therapeutic agent to reduce arteriovenous fistula (AVF) failures, a significant unmet clinical need in end stage renal disease (ESRD) patients undergoing hemodialysis.
› Verified 8 days ago
Mr. John Francis Schmidt, R. PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 609 Commercial St, Emporia, KS 66801 Phone: 620-343-2323 | |
Sasha Sosa, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1502 Industrial Rd, Emporia, KS 66801 Phone: 620-342-3301 Fax: 620-342-3318 | |
Dr. Jordan Kline, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1400 W 12th Ave, Emporia, KS 66801 Phone: 620-342-1242 Fax: 620-342-1243 | |
John Ulrey, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2301 Industrial Rd, Emporia, KS 66801 Phone: 620-342-7711 | |
Mark Rogers, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1502 Industrial Rd, Emporia, KS 66801 Phone: 620-342-3301 | |
Rahel Tibebu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1215 Merchant St, Emporia, KS 66801 Phone: 620-343-0121 | |
Dr. Gail Barrett, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2301 Industrial Rd, Emporia, KS 66801 Phone: 620-342-7711 Fax: 620-342-7747 |